1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porters Fiver Forces Analysis 38
3 Segmentation of North America Market by Product 43
3.1 Market Overview by Product 43
3.2 Kits & Assays 45
3.3 Analyzers & Instruments 46
3.4 Software & Services 47
4 Segmentation of North America Market by Technology 48
4.1 Market Overview by Technology 48
4.2 Polymerase Chain Reaction (PCR) 50
4.2.1 Real-Time PCR (rt-PCR) 51
4.2.2 Digital PCR (d-PCR) 52
4.3 Isothermal Nucleic Acid Amplification Technology (INAAT) 53
4.4 Genetic Sequencing-based Technology 54
4.5 Microarray-based Technology 55
4.6 Other Technologies 56
5 Segmentation of North America Market by Application 57
5.1 Market Overview by Application 57
5.2 Infectious Disease 59
5.2.1 Respiratory Infections 61
5.2.2 Hospital Acquired Infections 62
5.2.3 Sexually Transmitted Infections 63
5.3 Gastrointestinal Infections 64
5.4 Oncology 65
5.5 Hepatitis 66
5.6 Prenatal/Neonatal Testing 67
5.7 Other Applications 68
6 Segmentation of North America Market by End User 69
6.1 Market Overview by End User 69
6.2 Hospitals 71
6.3 Clinics & Diagnostic Centers 72
6.4 Research and Academic Institutes 73
6.5 Other End Users 74
7 North America Market 2019-2030 by Country 76
7.1 Overview of North America Market 76
7.2 U.S. 79
7.3 Canada 83
7.4 Mexico 85
8 Competitive Landscape 87
8.1 Overview of Key Vendors 87
8.2 New Product Launch, Partnership, Investment, and M&A 91
8.3 Company Profiles 92
Abacus Diagnostica Oy 92
Abbott Laboratories 94
Alere Inc. 95
Biocartis Group NV 96
Biomerieux SA 97
Bio-Rad Laboratories Inc 98
Danaher Corporation 99
DiaSorin S.p.A 100
DxNA LLC. 101
F. Hoffmann-La Roche Ltd. 102
Hologic, Inc. 103
Luminex Corporation 104
Meridian Bioscience Inc. 105
Mesa Biotech Inc. 106
QIAGEN N.V. 107
QuantuMDx Group Ltd. 108
Quidel Corporation 109
Spartan Biosciences Inc. 110
Thermo Fisher Scientific 111
9 Investing in North America Market: Risk Assessment and Management 112
9.1 Risk Evaluation of North America Market 112
9.2 Critical Success Factors (CSFs) 115
Related Reports and Products 118